{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:37:55Z","timestamp":1785148675203,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":681,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41379-020-0610-4","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T07:03:53Z","timestamp":1594105433000},"page":"542-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Histopathologic features of breast cancer in Li\u2013Fraumeni syndrome"],"prefix":"10.1016","volume":"34","author":[{"given":"M. Gabriela","family":"Kuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan L.","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0610-4_bib1","series-title":"Breast tumours","author":"WHO Classification of Tumours Editorial Board.","year":"2019"},{"key":"10.1038\/s41379-020-0610-4_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10549-012-1993-9","article-title":"Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort","volume":"133","author":"Masciari","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-020-0610-4_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jso.24579","article-title":"Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening","volume":"115","author":"Verdial","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1038\/s41379-020-0610-4_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/humu.22559","article-title":"Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome","volume":"35","author":"Kamihara","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1038\/s41379-020-0610-4_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41525-018-0074-3","article-title":"Rare TP53 variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family","volume":"3","author":"AlHarbi","year":"2018","journal-title":"NPJ Genom Med"},{"key":"10.1038\/s41379-020-0610-4_bib6","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0610-4_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jmg.2010.078113","article-title":"A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations","volume":"47","author":"Wilson","year":"2010","journal-title":"J Med Genet"},{"key":"10.1038\/s41379-020-0610-4_bib8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/cncr.26377","article-title":"Early onset HER2-positive breast cancer is associated with germline TP53 mutations","volume":"118","author":"Melhem-Bertrandt","year":"2012","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0610-4_bib9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases","volume":"349","author":"Lakhani","year":"1997","journal-title":"Lancet"},{"key":"10.1038\/s41379-020-0610-4_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/modpathol.3800453","article-title":"The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications","volume":"18","author":"Honrado","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0610-4_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cancergen.2012.06.008","article-title":"Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium","volume":"205","author":"Mai","year":"2012","journal-title":"Cancer Genet"},{"key":"10.1038\/s41379-020-0610-4_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/1097-0142(194907)2:4<635::AID-CNCR2820020411>3.0.CO;2-Q","article-title":"The relatively favorable prognosis of medullary carcinoma of the breast","volume":"2","author":"Moore","year":"1949","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0610-4_bib13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N","article-title":"Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up","volume":"40","author":"Ridolfi","year":"1977","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0610-4_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0610-4_bib15","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0610-4_bib16","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-020-0610-4_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10689-007-9172-6","article-title":"Hereditary diffuse gastric cancer: association with lobular breast cancer","volume":"7","author":"Schrader","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1038\/s41379-020-0610-4_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pas.0000213351.49767.0f","article-title":"BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays","volume":"31","author":"Bane","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0610-4_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2626","article-title":"Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations","volume":"12","author":"Banneau","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-020-0610-4_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-016-0758-5","article-title":"Patient survival and tumor characteristics associated with CHEK2:p.I157T\u2014findings from the Breast Cancer Association Consortium","volume":"18","author":"Muranen","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-020-0610-4_bib21","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1158\/1078-0432.CCR-13-2943","article-title":"TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance","volume":"20","author":"Silwal-Pandit","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0610-4_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1006425809069","article-title":"P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers","volume":"65","author":"Done","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-020-0610-4_bib23","first-page":"67","article-title":"p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data","volume":"71","author":"O'Malley","year":"1994","journal-title":"Lab Investig"},{"key":"10.1038\/s41379-020-0610-4_bib24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0610-4_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/cjp2.133","article-title":"Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)","volume":"5","author":"Packwood","year":"2019","journal-title":"J Pathol Clin Res"},{"key":"10.1038\/s41379-020-0610-4_bib26","doi-asserted-by":"crossref","unstructured":"Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 2014;106:dju055.","DOI":"10.1093\/jnci\/dju055"},{"key":"10.1038\/s41379-020-0610-4_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/95.2.142","article-title":"Quantitative association between HER-2\/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer","volume":"95","author":"Konecny","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0610-4_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10549-014-2983-x","article-title":"Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer","volume":"145","author":"Lee","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-020-0610-4_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAI.0b013e3181b94ff1","article-title":"Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5\/6, and EGFR","volume":"18","author":"Bhargava","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/s41379-020-0610-4_bib30","first-page":"1","article-title":"Tumors associated with p53 germline mutations: a synopsis of 91 families","volume":"150","author":"Kleihues","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-020-0610-4_bib31","first-page":"6643","article-title":"Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype","volume":"63","author":"Olivier","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-020-0610-4_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/02841860802047411","article-title":"A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients","volume":"47","author":"Alsner","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1038\/s41379-020-0610-4_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.2784","article-title":"The role of mutant p53 in human cancer","volume":"223","author":"Goh","year":"2011","journal-title":"J Pathol"},{"key":"10.1038\/s41379-020-0610-4_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-012-2375-z","article-title":"Prevalence of germline TP53 mutations in HER2+ breast cancer patients","volume":"139","author":"Rath","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-020-0610-4_bib35","first-page":"929","article-title":"Genetic mutations and expression of p53 in non-invasive breast lesions","volume":"3","author":"Mao","year":"2010","journal-title":"Mol Med Rep"},{"key":"10.1038\/s41379-020-0610-4_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2004.03.010","article-title":"Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast","volume":"212","author":"Keohavong","year":"2004","journal-title":"Cancer Lett"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0610-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:37:13Z","timestamp":1760229433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222006548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0893395222006548"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0610-4","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathologic features of breast cancer in Li\u2013Fraumeni syndrome","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0610-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}